Overview

Safety and Efficacy of Anecortave Acetate in Patients With Open-Angle Glaucoma

Status:
Completed
Trial end date:
2009-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study was to evaluate the safety and intraocular pressure (IOP)-lowering efficacy of anecortave acetate for treatment of elevated IOP in patients with open-angle glaucoma.
Phase:
Phase 2
Details
Lead Sponsor:
Alcon Research
Treatments:
Anecortave
Hydrocortisone